Movatterモバイル変換

[0]ホーム
URL:

Jung et al., 2002 - Google Patents

Chemistry, pharmacology and safety: milbemycin oxime

Jung et al., 2002

ViewPDF
Document ID
1031974441621000399
Author
Jung M
Saito A
Buescher G
Maurer M
Graf J
Publication year
Publication venue
Macrocyclic lactones in antiparasitic therapy

External Links

Snippet

The discovery of milbemycins dates back to 1967 when A. Aoki at Hokkai Sankyo, found that the metabolite B-41 (actually a mixture of several structurally similar compounds) from the fermentation of an actinomycete showed dramatic acaricidal activity against plant mites and …
Continue reading atlibrary.knu.edu.af (PDF) (other versions)

Classifications

The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Similar Documents

PublicationPublication DateTitle
US9084719B2 (en)Compositions and method for treating infection in cattle and swine
Shoop et al.Chemistry, pharmacology and safety of the macrocyclic lactones: ivermectin, abamectin and eprinomectin.
Perez et al.Comparison of the pharmacokinetics of moxidectin (Equest®) and ivermectin (Eqvalan®) in horses
Pérez et al.Faecal excretion profile of moxidectin and ivermectin after oral administration in horses
PT98117B (en) 4 &#34;-DESOXI-4&#34; -EPI-METHYLAMINO-AVERMECTIN B1A / BIB STATISTICS &#34;
RU2359667C2 (en)Compositions and method of treatment of microbic and parasitogenic infections at cattle and other animals
AU605917B2 (en)Prevention of fescue toxicosis in grazing animals
US20250032455A1 (en)Nitroimidazole formulations
Jung et al.Chemistry, pharmacology and safety: milbemycin oxime
Weaver et al.Mycotoxin-induced abortions in swine
CN1038475C (en) Anticoccidial composition
Rock et al.Chemistry, pharmacology and safety: moxidectin
JPH0244285B2 (en)
EP0252380B1 (en)Antibiotic ll-e19020 alpha and beta
JPH06107677A (en)Method of glycosylating avermectin compound
RU2279874C1 (en)Preparation for prophylaxis and treatment of horse with helminthism
AU2003258756B2 (en)Oleaginous oral antiparasitic compositions
Schildknecht et al.Antiparasitic activity of natural and semisynthetic monensin urethanes
US6764999B2 (en)Nasal delivery of parasiticides
AU2021106734A4 (en)Control of nematodes
Kabir et al.Assessment of acaricidal efficacy of ivermectin against ectoparasitic skin lesions in goats
NZ537760A (en)Worming formulations comprising a macrocyclic lactone and piperonyl butoxide
FR2572895A1 (en) FOOD AND FOOD PREMIX WITH INCREASED ANTICOCCIDAL EFFECTIVENESS
LivingstoneSeS H „N
WO2010126857A1 (en)Parasiticidal combinations of macrocyclic lactones and polyether antibiotics
[8]ページ先頭
©2009-2025 Movatter.jp